Invention Grant
- Patent Title: HCV NS3 protease inhibitors
- Patent Title (中): HCV NS3蛋白酶抑制剂
-
Application No.: US13960343Application Date: 2013-08-06
-
Publication No.: US08987195B2Publication Date: 2015-03-24
- Inventor: Thomas Bara , Sathesh Bhat , Dipshikha Biswas , Linda Brockunier , Duane A. Burnett , Samuel Chackalamannil , Mariappan V. Chelliah , Austin Chen , Martin Clasby , Vince J. Colandrea , Zhuyan Guo , Yongxin Han , Charles Jayne , Hubert Josien , Karen Marcantonio , Shouwu Miao , Santhosh Neelamkavil , Patrick Pinto , Murali Rajagopalan , Unmesh Shah , Francisco Velazquez , Srikanth Venkatraman , Yan Xia
- Applicant: Merck Sharp & Dohme Corp. , Merck Canada Inc.
- Applicant Address: US NJ Rahway CA Kirkland, Quebec
- Assignee: Merck Sharp & Dohme Corp.,Merck Canada Inc.
- Current Assignee: Merck Sharp & Dohme Corp.,Merck Canada Inc.
- Current Assignee Address: US NJ Rahway CA Kirkland, Quebec
- Agent Anna Cocuzzo; Henry P. Wu
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K5/08 ; A61K38/06 ; A61K45/06 ; C07D491/22 ; C07D419/00
Abstract:
The present invention relates to hepatitis C virus (HCV) NS3 protease inhibitors containing a spirocyclic moeity, uses of such compounds, and synthesis of such compounds.
Public/Granted literature
- US20140057836A1 HCV NS3 PROTEASE INHIBITORS Public/Granted day:2014-02-27
Information query
IPC分类:
